- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 167 results
Webinar
mayo 12, 2026
Food & Beverage: Ultra-Processed Foods
Webinar
abril 27, 2026
Securities Litigation and Life Sciences: A Review of the Risks Facing Manufacturers of FDA-Regulated Drugs and Medical Devices
Webinar
abril 23, 2026
AI in EU Pharma: Navigating Efficiency, Innovation and Regulatory Challenges
Webinar
marzo 25, 2026
Using Science Offensively in Litigation: Strategies From Recent Trials in Hellhole Jurisdictions
Webinar
marzo 12, 2026
Key Revisions of the EU General Pharmaceutical Legislation
Webinar
marzo 10, 2026
Can the EU Deliver On Its (Privacy) Simplification Agenda? A Practitioners' Views
Webinar
marzo 4, 2026
Understanding Supplemental Medicaid Opportunities via the Medicaid DSH Program
Webinar
febrero 26, 2026
2026 CA MCLE Institute
Webinar
febrero 25, 2026
Data Dividends vs. Red Lines: Navigating EU Data Laws and Cyber Threats in Pharma’s Data‑Driven Era
Webinar
febrero 25, 2026
What’s Next After Section 122 Temporary Tariffs? Strategic Considerations for Upcoming Section 301 Investigations
Webinar
febrero 24, 2026
Reading the Tea Leaves: Top 10 Enforcement and Regulatory Risks for Device Makers in 2026
Webinar
febrero 18, 2026
Is the NSA IDR Process Dead?